This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 14.29% and 5%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens (WBA) to Offer Health Services to Ohio Medicaid Members
by Zacks Equity Research
Walgreens' (WBA) subsidiary teams up with Buckeye Health Plan to provide wellness services through Walgreens Health Corner locations in Ohio.
Walgreens (WBA) Starts COVID Jabs for 3-Year Olds & Above
by Zacks Equity Research
Walgreens Boots (WBA) continues to serve communities with COVID testing and vaccinations to fight the pandemic.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $39.32, moving -0.88% from the previous trading session.
Kroger (KR) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Kroger (KR) delivered earnings and revenue surprises of 13.28% and 0.84%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $40.20, moving -0.2% from the previous trading session.
Amazon (AMZN) Plans to Debut Drone Delivery Service This Year
by Zacks Equity Research
Amazon (AMZN) gears up to offer drone delivery service later this year, for which it has picked Lockeford, CA, as the first location.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $43.39, marking a +0.58% move from the previous day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $43.83 in the latest trading session, marking a +0.27% move from the prior day.
Walgreens Boots (WBA) Omnichannel Aids Growth Amid Cost Woes
by Zacks Equity Research
The continued acceleration of Walgreens' (WBA) omnichannel offerings and a significant rise in MyWalgreens membership are notable upsides in recent times.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $42.46, marking a +0.9% move from the previous day.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $40.61, marking a -1.36% move from the previous day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $43.55 in the latest trading session, marking a +0.9% move from the prior day.
Company News for May 13, 2022
by Zacks Equity Research
Companies in The News Are: ABC, WBA, COIN, CEG, TPR
Here's Why You Should Hold on to Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens (WBA) owing to the recent product launches.
Walgreens (WBA) Expands Medical Care Offerings in California
by Zacks Equity Research
Walgreens' (WBA) new initiative is intended to reduce care gaps and advance care management by providing access to more affordable and convenient services.
Company News for Apr 1, 2022
by Zacks Equity Research
Companies In The News Are: WBA, XOM, JPM, VNET.
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Strong execution across business segments, led by COVID-19 vaccinations and testing, drove Walgreens' (WBA) fiscal second-quarter top line.
Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 14.39% and 0.19%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Micron Technology, Walgreens, Paychex and JPMorgan are part of Zacks Earnings Preview
by Zacks Equity Research
Micron Technology, Walgreens, Paychex and JPMorgan are part of Zacks Earnings Preview.
Breaking Down the Outlook for S&P 500 Margins
by Sheraz Mian
Revisions to the 2022 Q1 estimates are mixed, with estimates for 9 of the 16 Zacks sectors going down since the start of January, with the Consumer Discretionary, Transportation and Aerospace sectors suffering significant estimate cuts...
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $47.43 in the latest trading session, marking a +0.11% move from the prior day.
Walgreens (WBA), Village MD Plan to Expand Into New Hampshire
by Zacks Equity Research
Walgreens (WBA) and VillageMD are working together to make it easier for the communities to access high-quality, coordinated primary care and pharmacy services.
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS, WBA and RAD are likely to gain the most. However, reimbursement challenges are hurting the industry's health.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.17, marking a +0.54% move from the previous day.